LHC Group (NASDAQ:LHCG) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued to investors on Tuesday, January 9th.
According to Zacks, “LHC Group is the preferred post-acute care partner for hospitals, physicians and families nationwide. From home health and hospice care to long-term acute care and community-based services, LHC delivers high-quality, cost-effective care that empowers patients to manage their health at home. More than 60 leading hospitals and health systems around the country have partnered with LHC Group to deliver patient-centered care in the home. More hospitals, physicians and families choose LHC Group, because our 13,000-plus employees in 26 states are united by a single, shared purpose: It’s all about helping people. “
Several other equities analysts have also weighed in on the stock. ValuEngine lowered shares of LHC Group from a “buy” rating to a “hold” rating in a report on Friday, December 1st. SunTrust Banks restated a “buy” rating and issued a $75.00 price objective on shares of LHC Group in a report on Friday, November 3rd. Royal Bank of Canada upped their target price on shares of LHC Group from $70.00 to $81.00 and gave the stock an “outperform” rating in a research note on Tuesday, November 7th. Oppenheimer upped their target price on shares of LHC Group from $68.00 to $80.00 and gave the stock an “outperform” rating in a research note on Tuesday, November 7th. Finally, Robert W. Baird set a $71.00 price objective on shares of LHC Group and gave the company a “hold” rating in a research report on Tuesday, November 28th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and nine have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average target price of $77.10.
LHC Group (LHCG) traded down $1.17 during mid-day trading on Tuesday, hitting $61.72. 236,170 shares of the stock were exchanged, compared to its average volume of 258,342. The stock has a market capitalization of $1,128.18, a PE ratio of 26.49, a P/E/G ratio of 1.65 and a beta of 0.71. LHC Group has a twelve month low of $46.18 and a twelve month high of $76.14. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.24.
Several hedge funds have recently added to or reduced their stakes in the company. BlackRock Inc. lifted its stake in shares of LHC Group by 18.1% in the 2nd quarter. BlackRock Inc. now owns 2,325,510 shares of the health services provider’s stock worth $157,879,000 after acquiring an additional 356,014 shares during the period. Vanguard Group Inc. lifted its stake in shares of LHC Group by 2.2% in the 2nd quarter. Vanguard Group Inc. now owns 1,464,057 shares of the health services provider’s stock worth $99,395,000 after acquiring an additional 32,049 shares during the period. Dimensional Fund Advisors LP increased its holdings in shares of LHC Group by 1.1% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,275,663 shares of the health services provider’s stock valued at $86,604,000 after purchasing an additional 13,347 shares in the last quarter. Ameriprise Financial Inc. increased its holdings in shares of LHC Group by 6.5% in the 3rd quarter. Ameriprise Financial Inc. now owns 616,829 shares of the health services provider’s stock valued at $43,747,000 after purchasing an additional 37,873 shares in the last quarter. Finally, Rothschild Asset Management Inc. increased its holdings in shares of LHC Group by 5.0% in the 3rd quarter. Rothschild Asset Management Inc. now owns 575,153 shares of the health services provider’s stock valued at $40,790,000 after purchasing an additional 27,613 shares in the last quarter. Institutional investors own 85.85% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This news story was originally published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this news story on another website, it was illegally stolen and republished in violation of United States & international trademark and copyright law. The legal version of this news story can be viewed at https://www.dispatchtribunal.com/2018/02/04/lhc-group-lhcg-stock-rating-lowered-by-zacks-investment-research.html.
About LHC Group
LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.
Get a free copy of the Zacks research report on LHC Group (LHCG)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.